Duality Advisers, LP Horizon Therapeutics Public LTD CO Transaction History

Duality Advisers, LP

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 03, 2022	SELL	$58.92 - $84.67 $160,026 - $229,963	-2,716 Reduced 7.36%	34,196 $2.12 Million
Q2 2022 Aug 08, 2022	BUY	$79.4 - $116.36 $2.93 Million - $4.3 Million	36,912 New	36,912 $2.94 Million
Q3 2021 Nov 08, 2021	SELL	$91.91 - $110.37 $614,602 - $738,044	-6,687 Closed	0 $0
Q2 2021 Aug 09, 2021	BUY	$86.24 - $95.92 $576,686 - $641,417	6,687 New	6,687 $626,000
Q1 2021 May 13, 2021	SELL	$71.83 - $95.48 $2.21 Million - $2.94 Million	-30,826 Closed	0 $0
Q4 2020 Feb 09, 2021	BUY	$67.0 - $84.39 $2.07 Million - $2.6 Million	30,826 New	30,826 $2.26 Million

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Duality Advisers, LP, based on Form 13F filings with the SEC.

Stay updated on Duality Advisers, LP with notifications on news.